{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:46:51Z","timestamp":1776728811569,"version":"3.51.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515010318"],"award-info":[{"award-number":["2024A1515010318"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program Key Projects","doi-asserted-by":"crossref","award":["2024B03J1254"],"award-info":[{"award-number":["2024B03J1254"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05706-y","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:15:25Z","timestamp":1773321325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug-coated balloon combined with stent versus stent alone for femoropopliteal disease: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Haoliang","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunchong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengde","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"5706_CR1","doi-asserted-by":"crossref","unstructured":"Gornik HL, Aronow HD, Goodney PP, et al. 2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149:e1313\u2013410.","DOI":"10.1161\/CIR.0000000000001251"},{"key":"5706_CR2","first-page":"14","volume":"27","author":"S Banerjee","year":"2015","unstructured":"Banerjee S, Pershwitz G, Sarode K, et al. Stent and Non-Stent Based Outcomes of Infrainguinal Peripheral Artery Interventions From the Multicenter XLPAD Registry. J Invasive Cardiol. 2015;27:14\u20138.","journal-title":"J Invasive Cardiol"},{"key":"5706_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41569-021-00663-9","volume":"19","author":"J Golledge","year":"2022","unstructured":"Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat Rev Cardiol. 2022;19:456\u201374.","journal-title":"Nat Rev Cardiol"},{"key":"5706_CR4","doi-asserted-by":"crossref","unstructured":"Dotter CT, Judkins MP. PERCUTANEOUS TRANSLUMINAL TREATMENT OF ARTERIOSCLEROTIC OBSTRUCTION. Radiology. 1965;84:631\u201343.","DOI":"10.1148\/84.4.631"},{"key":"5706_CR5","doi-asserted-by":"publisher","first-page":"107602962091597","DOI":"10.1177\/1076029620915979","volume":"26","author":"K Wang","year":"2020","unstructured":"Wang K, Li Y, Gao F, et al. Efficacy and Safety of TurboHawk Plaque Rotation Combined With Drug-coated Balloon in Treating Diabetic Patients With Lower Extremity Arterial Disease. Clin Appl Thromb Hemost. 2020;26:1076029620915979.","journal-title":"Clin Appl Thromb Hemost"},{"key":"5706_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/15266028221092979","volume":"30","author":"X Jiang","year":"2023","unstructured":"Jiang X, Ju S, Chen B, et al. Safety and Effectiveness of Excimer Laser Ablation Combined With Drug-Coated Balloon for Atherosclerotic Obliterans in the Lower Extremity. J Endovasc Ther. 2023;30:721\u20139.","journal-title":"J Endovasc Ther"},{"key":"5706_CR7","first-page":"679","volume":"60","author":"SW de Boer","year":"2019","unstructured":"de Boer SW, de Vries J, Werson DA, et al. Drug coated balloon supported Supera stent versus Supera stent in intermediate and long-segment lesions of the superficial femoral artery: 2-year results of the RAPID Trial. J Cardiovasc Surg (Torino). 2019;60:679\u201385.","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"5706_CR8","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1161\/CIRCULATIONAHA.116.025329","volume":"135","author":"I Ott","year":"2017","unstructured":"Ott I, Cassese S, Groha P, et al. Randomized Comparison of Paclitaxel-Eluting Balloon and Stenting Versus Plain Balloon Plus Stenting Versus Directional Atherectomy for Femoral Artery Disease (ISAR-STATH). Circulation. 2017;135:2218\u201326.","journal-title":"Circulation"},{"key":"5706_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.avsg.2024.06.022","volume":"109","author":"X Tang","year":"2024","unstructured":"Tang X, Ma H, Zhou G, et al. Efficacy of Supera Stent in the Treatment of Complex Femoropopliteal Artery Lesions: A Short-Term Result Analysis of Real-World Evidence. Ann Vasc Surg. 2024;109:101\u201310.","journal-title":"Ann Vasc Surg"},{"key":"5706_CR10","unstructured":"Antoniou GA, Antoniou SA, Mani K. Enhancing the Reporting of Systematic Reviews and Meta-Analyses in Vascular Surgery. PRISMA; 2020."},{"key":"5706_CR11","doi-asserted-by":"crossref","unstructured":"Page MA-O, McKenzie JE, Bossuyt PM et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","DOI":"10.31222\/osf.io\/v7gm2"},{"key":"5706_CR12","doi-asserted-by":"publisher","first-page":"e1001380","DOI":"10.1371\/journal.pmed.1001380","volume":"10","author":"RD Riley","year":"2013","unstructured":"Riley RD, Hayden JA, Steyerberg EW, et al. Prognosis Research Strategy (PROGRESS) 2: prognostic factor research. PLoS Med. 2013;10:e1001380.","journal-title":"PLoS Med"},{"key":"5706_CR13","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1177\/1526602817725062","volume":"24","author":"SW de Boer","year":"2017","unstructured":"de Boer SW, van den Heuvel DAF, de Vries-Werson DAB, et al. Short-term Results of the RAPID Randomized Trial of the Legflow Paclitaxel-Eluting Balloon With Supera Stenting vs Supera Stenting Alone for the Treatment of Intermediate and Long Superficial Femoral Artery Lesions. J Endovasc Ther. 2017;24:783\u201392.","journal-title":"J Endovasc Ther"},{"key":"5706_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12928-024-00997-4","volume":"39","author":"S Iwata","year":"2024","unstructured":"Iwata S, Suzuki R, Hosoi Y, et al. Evaluation of the efficacy of combined device strategies for long femoropopliteal artery disease. Cardiovasc Interv Ther. 2024;39:273\u201383.","journal-title":"Cardiovasc Interv Ther"},{"key":"5706_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1024\/0301-1526\/a000785","volume":"48","author":"M Lichtenberg","year":"2019","unstructured":"Lichtenberg M, Breuckmann F, Kramer V, et al. Effectiveness of the Pulsar-18 self-expanding stent with optional drug-coated balloon angioplasty in the treatment of femoropopliteal lesions - the BIOFLEX PEACE All-Comers Registry. Vasa. 2019;48:425\u201332.","journal-title":"Vasa"},{"key":"5706_CR16","unstructured":"Antoniou SA, Antoniou GA. The GRADE approach to appraising the evidence or how to increase the credibility of your research."},{"key":"5706_CR17","doi-asserted-by":"crossref","unstructured":"Xiao L, Gu S, Chen Y et al. Midterm Results of Drug-Coated Balloon and Bare Metal Stent in the Treatment of TASCII C\/D Femoropopliteal Artery Occlusive Disease: A Retrospective Multicenter Study. J Endovasc Ther 2023:15266028231209932.","DOI":"10.1177\/15266028231209932"},{"key":"5706_CR18","doi-asserted-by":"publisher","first-page":"21327","DOI":"10.1038\/s41598-022-25634-z","volume":"12","author":"P Krishnan","year":"2022","unstructured":"Krishnan P, Sharma R, Avadhani S, et al. Drug coated balloon improves outcomes of sub-optimal Supera deployment in the intermediate term. Sci Rep. 2022;12:21327.","journal-title":"Sci Rep"},{"key":"5706_CR19","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","volume":"366","author":"DJ Adam","year":"2005","unstructured":"Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925\u201334.","journal-title":"Lancet"},{"key":"5706_CR20","first-page":"139","volume":"94","author":"M Anantha-Narayanan","year":"2019","unstructured":"Anantha-Narayanan M, Shah SM, Jelani QU, et al. Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: An updated meta-analysis of randomized controlled trials. Catheter Cardiovasc Interv. 2019;94:139\u201348.","journal-title":"Catheter Cardiovasc Interv"},{"key":"5706_CR21","doi-asserted-by":"crossref","unstructured":"Tataru DA, Lazar FL, Onea HL et al. Benefits and Challenges of Drug-Coated Balloons in Peripheral Artery Disease: From Molecular Mechanisms to Clinical Practice. Int J Mol Sci 2024;25.","DOI":"10.3390\/ijms25168749"},{"key":"5706_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejvs.2013.05.010","volume":"46","author":"JM Davaine","year":"2013","unstructured":"Davaine JM, Qu\u00e9rat J, Guyomarch B, et al. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year. Eur J Vasc Endovasc Surg. 2013;46:201\u201312.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"5706_CR23","doi-asserted-by":"crossref","unstructured":"Lukic B, Miletic M, Milosevic S et al. Endovascular Treatment of Femoro-Popliteal Disease with the Supera Stent: A Single Center Experience. J Clin Med 2025;14.","DOI":"10.3390\/jcm14051704"},{"key":"5706_CR24","doi-asserted-by":"publisher","first-page":"e005654","DOI":"10.1161\/CIRCINTERVENTIONS.117.005654","volume":"11","author":"D Scheinert","year":"2018","unstructured":"Scheinert D, Micari A, Brodmann M, et al. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease. Circ Cardiovasc Interv. 2018;11:e005654.","journal-title":"Circ Cardiovasc Interv"},{"key":"5706_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1586\/erd.12.67","volume":"10","author":"B Schnorr","year":"2013","unstructured":"Schnorr B, Albrecht T. Drug-coated balloons and their place in treating peripheral arterial disease. Expert Rev Med Devices. 2013;10:105\u201314.","journal-title":"Expert Rev Med Devices"},{"key":"5706_CR26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jcin.2018.03.046","volume":"11","author":"T Bisdas","year":"2018","unstructured":"Bisdas T, Beropoulis E, Argyriou A, et al. 1-Year All-Comers Analysis of the Eluvia Drug-Eluting Stent for Long Femoropopliteal Lesions After Suboptimal Angioplasty. JACC Cardiovasc Interv. 2018;11:957\u201366.","journal-title":"JACC Cardiovasc Interv"},{"key":"5706_CR27","doi-asserted-by":"publisher","first-page":"e025677","DOI":"10.1161\/JAHA.122.025677","volume":"12","author":"Y Soga","year":"2023","unstructured":"Soga Y, Takahara M, Iida O, et al. Vessel Patency and Associated Factors of Drug-Coated Balloon for Femoropopliteal Lesion. J Am Heart Assoc. 2023;12:e025677.","journal-title":"J Am Heart Assoc"},{"key":"5706_CR28","first-page":"1259","volume":"89","author":"LA Garcia","year":"2017","unstructured":"Garcia LA, Rosenfield KR, Metzger CD, et al. SUPERB final 3-year outcomes using interwoven nitinol biomimetic supera stent. Catheter Cardiovasc Interv. 2017;89:1259\u201367.","journal-title":"Catheter Cardiovasc Interv"},{"key":"5706_CR29","doi-asserted-by":"crossref","unstructured":"Cosacco AM, Zenunaj G, Acciarri P et al. Primary Drug-Coated Balloon Versus Drug-Eluting Stent for Native Atherosclerotic Femoropopliteal Lesions: An Updated Systematic Review and Meta-Analysis. J Endovasc Ther 2025:15266028251344877.","DOI":"10.1177\/15266028251344877"},{"key":"5706_CR30","doi-asserted-by":"publisher","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","volume":"7","author":"K Katsanos","year":"2018","unstructured":"Katsanos K, Spiliopoulos S, Kitrou P, et al. Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2018;7:e011245.","journal-title":"J Am Heart Assoc"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05706-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05706-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05706-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:20:29Z","timestamp":1776727229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05706-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5706"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05706-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"339"}}